close
MENU
Hot Topic Hawke’s Bay
How to guide
How to guide
Home
The NBR List
NBR View
NBR Marketplace

Categories

General Business Investment Economics Te Ao Māori Politics Infrastructure Australia Tech & Innovation Finance Law Professional Services Primary Industries Retail Property Deals Aviation News Comings & Goings

Analysis

All Economy Matters Edwards on Politics Hunter’s Corner Last Word Margin Call On the Money Shoeshine Underarm NBR Focus

Featured

Podcasts Audio Articles Entrepreneurs Your Business Beehive Banter Morning Brew Toil & Trouble NZ Aviation News Back Issues Market Outlook Dollars & Sense Private Bin Opinion (Archive) NBR Radar (Archive) NBR Rich List (Archive)
Hot Topic Hawke’s Bay
Investment
3 mins to read
6

Rua latest cannabis firm to sign European deal

NZX’s three cannabis companies have all signed supply agreements in the past month or so.

Rua Bioscience's outgoing chief executive Rob Mitchell.

Andrew Bevin Tue, 26 Jul 2022

Rua Bioscience is the latest New Zealand cannabis firm to pen a supply agreement with a European distributor, following Cannasouth earlier in the month.

Rua, an NZX-listed medical cannabis business based on the east coast, announced this morning it had entered into a five-year deal with Motagon, a

Want to read more? It's easy.

Choose your best value subscription option

Student

Exclusive offer for uni students studying at a New Zealand university (valued at $499).
View terms and conditions.
Individual
Group membership
NBR Marketplace

Yearly Premium Online Subscription

NZ$499.00 / yearly

Monthly Premium Online Subscription

NZ$44.95 / monthly

Smartphone Only Subscription

NZ$24.95 / monthly

Premium Group Membership 10 Users

NZ$350+GST / monthly

$35 per user - Pay by monthly credit card debit

Premium Group Membership 20 Users

NZ$600+GST / monthly

$30 per user - Pay by monthly credit card debit

Premium Group Membership 50 Users

NZ$1250+GST / monthly

$25 per user - Pay by monthly credit card debit

Premium Group Membership 100 Users

NZ$1875+GST / monthly

$18.75 per user - Pay by monthly credit card debit

Yearly Premium Online Subscription + NBR Marketplace

NZ$499.00 / yearly

Already have an account? Login
Andrew Bevin Tue, 26 Jul 2022
Contact the Writer: andrew@nbr.co.nz
News tip? Question? Typo? Let us know: editor@nbr.co.nz
© All content copyright NBR. Do not reproduce in any form without permission, even if you have a paid subscription.
Tags
Rua Bioscience medical cannabis Cannasouth Greenfern
Company profile
Powered by: nzx logo
Change:
Price
Previous Close
Turnover
Movement
Volume
Avg Daily Volume
Daily High
Daily Low
52 Week High
52 Week Low
Related News
Comings & Goings
1

Anna Stove appointed managing director of Rua Bioscience
Investment
5

Cannasouth shares jump on $15m distribution deal
Investment

Greenfern releases annual report day late, details new deal
Investment
2

Rua Bioscience’s first CBD product now prescribable
General Business

New Zealand cannabis industry ripe for big pharma acquisitions

Investment
3

Rua purchases Zalm in $10m equity deal
Company profile
Powered by: nzx logo
Change:
Price
Previous Close
Turnover
Movement
Volume
Avg Daily Volume
Daily High
Daily Low
52 Week High
52 Week Low
Related News
Comings & Goings
1

Anna Stove appointed managing director of Rua Bioscience
Investment
5

Cannasouth shares jump on $15m distribution deal
Investment

Greenfern releases annual report day late, details new deal
Investment
2

Rua Bioscience’s first CBD product now prescribable
General Business

New Zealand cannabis industry ripe for big pharma acquisitions

Investment
3

Rua purchases Zalm in $10m equity deal
Rua latest cannabis firm to sign European deal
Investment,
94992
true
Subscribe Login